Eckert & Ziegler’s G
Eckert & Ziegler’s GalliaPharm® distributed by Curium in France
March 01, 2021 19:15 ET | Curium
Berlin, Germany and Paris, France, March 01, 2021 (GLOBE NEWSWIRE) -- Eckert & Ziegler Radiopharma GmbH and Curium PET France have decided to reinforce their existing long term partnership by...
RadioMedix & Curium
RadioMedix & Curium Announce Permanent HCPCS Code for DetectnetTM (copper Cu 64 dotatate injection)
January 26, 2021 02:30 ET | Curium
St. Louis, MO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet a...
Radiomedix Curium CoBrand Logo .jpg
RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)
December 09, 2020 01:10 ET | Curium
ST. LOUIS, Dec. 09, 2020 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet...
RadioMedix and Curiu
RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.
September 08, 2020 13:52 ET | Curium
Houston, TX and St. Louis, MO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that DetectnetTM (copper Cu 64 dotatate injection) was approved by...
RadioMedix and Curiu
RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.
September 07, 2020 23:00 ET | Curium
Houston, TX and St. Louis, MO, Sept. 07, 2020 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that DetectnetTM (copper Cu 64 dotatate injection) was approved by...
Curium Announces Dru
Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe.
June 09, 2020 07:00 ET | Curium
St. Louis, MO, June 09, 2020 (GLOBE NEWSWIRE) -- Curium announced today that it has filed the first stand-alone Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) and has also...
Curium Announces App
Curium Announces Approval of Pulmotech™ MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration
March 24, 2020 02:00 ET | Curium
St. Louis, MO, March 24, 2020 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration (FDA) has approved Pulmotech MAA.  When labeled to technetium Tc 99m, Pulmotech...
RadioMedix and Curiu
RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA
March 11, 2020 19:15 ET | Curium
Houston, TX and St. Louis, MO, March 11, 2020 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced the U.S. Food and Drug Administration (FDA) has granted copper Cu 64...
Curium Acquires Zeva
Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio
March 03, 2020 05:00 ET | Curium
St. Louis, MO, March 03, 2020 (GLOBE NEWSWIRE) -- Curium and DMH Worldwide have closed a transaction in which Curium has acquired Zevacor Molecular.  Zevacor Molecular is a leader in the production...
RadioMedix and Curiu
RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application
January 07, 2020 05:15 ET | Curium
Houston and St Louis, Jan. 07, 2020 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the New Drug Application for copper Cu 64 dotatate injection was filed...